Send to

Choose Destination
Diabetes Spectr. 2017 May;30(2):101-106. doi: 10.2337/ds16-0048.

Phosphate Additive Avoidance in Chronic Kidney Disease.

Author information

New York University School of Medicine, Center for Healthful Behavior Change, New York, NY.
New York University Medical Center, Division of Nephrology, New York, NY.


IN BRIEF Dietary guidelines for patients with diabetes extend beyond glycemic management to include recommendations for mitigating chronic disease risk. This review summarizes the literature suggesting that excess dietary phosphorus intake may increase the risk of skeletal and cardiovascular disease in patients who are in the early stages of chronic kidney disease (CKD) despite having normal serum phosphorus concentrations. It explores strategies for limiting dietary phosphorus, emphasizing that food additives, as a major source of highly bioavailable dietary phosphorus, may be a suitable target. Although the evidence for restricting phosphorus-based food additives in early CKD is limited, diabetes clinicians should monitor ongoing research aimed at assessing its efficacy.

Supplemental Content

Full text links

Icon for PubMed Central Icon for NYU School of Medicine
Loading ...
Support Center